Miquel y Costas & Miquel (MCM) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
12 May, 2026Executive summary
Consolidated net sales for H1 2024 reached €164.1 million, down 2.1% year-over-year, mainly due to lower industrial product sales despite growth in the tobacco segment.
EBITDA increased by 8.2% to €44.1 million, and net profit rose 10.5% to €26.8 million compared to H1 2023.
Operating profit improved by 9.6% year-over-year, confirming margin recovery driven by commercial policies and easing energy cost pressures.
The group initiated its 2024-2026 investment plan, increasing net fixed assets by €2.0 million after €10.0 million in amortizations.
Financial highlights
Net sales: €164.1 million (down 2.1% year-over-year).
EBITDA: €44.1 million (up 8.2% year-over-year).
Operating profit: €34.1 million (up 9.6% year-over-year).
Net profit: €26.8 million (up 10.5% year-over-year).
Cash flow after tax: €36.8 million (up 8.6% year-over-year).
Outlook and guidance
Expects to maintain growth trajectory in Q3 2024 despite ongoing energy and raw material price volatility and geopolitical instability.
Reaffirms 2024 objectives, with continued investment in technology and logistics planned for H2.
Latest events from Miquel y Costas & Miquel
- EBITDA and net income grew despite lower sales, with positive outlook sustained.MCM
Q3 202412 May 2026 - Sales up 10.1% year-over-year, but net profit dipped 1.5% amid higher energy costs.MCM
Q1 202512 May 2026 - Slight revenue growth offset by lower profit as costs and FX pressures weighed on results.MCM
Q3 202512 May 2026 - Sales rose but profit declined due to margin pressure; outlook stable for full year.MCM
Q2 202512 May 2026 - Net profit up 14% to €48.7M, with stable sales and strong investment amid global uncertainties.MCM
Q4 202412 May 2026 - Revenue rose 1.5% but profits fell amid cost pressures and currency headwinds in 2025.MCM
Q4 202512 May 2026 - Sales and profits declined year-over-year, but sequential growth and investment support resilience.MCM
Q1 202612 May 2026